Free Trial
OTCMKTS:PCLOF

PharmaCielo (PCLOF) Stock Price, News & Analysis

PharmaCielo logo
$0.03 -0.01 (-13.64%)
As of 03:49 PM Eastern

About PharmaCielo Stock (OTCMKTS:PCLOF)

Advanced

Key Stats

Today's Range
$0.03
▼
$0.04
50-Day Range
$0.03
▼
$0.05
52-Week Range
$0.00
▼
$0.12
Volume
1,100 shs
Average Volume
58,716 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

PharmaCielo Ltd. is a Canadian cannabis company focused on the cultivation, processing and commercial development of medicinal cannabis products. Through its Colombian subsidiary, PharmaCielo Colombia Holdings S.A.S., the company has developed operations in Colombia, where it grows cannabis and produces cannabis-derived extracts and related ingredients.

The company has primarily pursued a business-to-business model, supplying cannabis oils, extracts and other cannabinoid products to pharmaceutical, nutraceutical and consumer packaged-goods companies. Its product development activities have included standardized cannabinoid formulations and white-label or private-label solutions for international markets, subject to applicable regulatory approvals.

PharmaCielo was established in the mid-2010s and has emphasized Colombia as a production base because of the country's climate and regulatory framework for medical cannabis. The company has sought to serve international medical-cannabis and wellness markets, although the availability of its products and the scope of its commercial operations may vary by jurisdiction.

AI Generated. May Contain Errors.

Receive PCLOF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PharmaCielo and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PCLOF Stock News Headlines

Trump goes "all-in" on Grand Canyon energy breakthrough
A drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of Saudi Arabia's largest oil field, with potential to last two million years. While the One Big Beautiful Bill Act eliminated federal credits for solar, wind, and EVs, this energy source was reclassified alongside oil and nuclear power and given eight years of tax credits. Google signed a 15-year contract, and Bill Gates committed $100 million. One company controls the entire supply chain behind this discovery.tc pixel
PharmaCielo Ltd. (PCLOF)
See More Headlines

PCLOF Stock Analysis - Frequently Asked Questions

PharmaCielo's stock was trading at $0.0372 at the beginning of the year. Since then, PCLOF shares have decreased by 13.2% and is now trading at $0.0323.

Shares of PCLOF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that PharmaCielo investors own include Innovative Industrial Properties (IIPR), NIO (NIO), Proto Labs (PRLB), Cresco Labs (CRLBF), Curaleaf (CURLF), Green Organic Dutchman (TGODF) and Canopy Growth (CGC).

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
OTCMKTS:PCLOF
CIK
N/A
Fax
N/A
Employees
268
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

This page (OTCMKTS:PCLOF) was last updated on 10/16/2026 by MarketBeat.com Staff.
From Our Partners